Email not displaying correctly? View it in your browser.
Mayo Clinic Digestive Diseases Physician Update e-Edition
February 2015
Follow us:   Facebook icon Twitter icon Youtube icon  
anchor arrowResearch | anchor arrowEducation | anchor arrowIn the Video Center | anchor arrowConsults & Referrals | anchor arrowResources
Patient Care

Small minority of patients have truly refractory IBD

Many patients with inflammatory bowel disease (IBD) fail to respond to standard therapies or lose response over time. But very few of them are truly refractory to treatment.

Rituximab promising for subset of AIP patients

The chimeric monoclonal anti-CD20 antibody, rituximab, can induce and maintain remission in steroid- and immunomodulator-refractory patients with autoimmune pancreatitis.

Pediatric Care

Studies prompt new look at pediatric CD

Two new studies suggest that the timing of childhood exposure to gluten doesn't increase the risk of celiac disease and that genetic testing may be better than serology for screening high-risk children younger than 2.


Trials to evaluate new agents for PSC

No effective treatments exist for primary sclerosing cholangitis other than liver transplantation. Mayo Clinic researchers are now enrolling patients in trials that will evaluate potential PSC therapies, including a medical probiotic, bile acid derivative, monoclonal antibody and curcumin.

Split-dose bowel prep now standard of care

Split dosing has consistently proved superior to evening-before dosing for bowel cleansing before colonoscopy. Same-day split-dose regimens may be even more effective.

See all Gastroenterology and Hepatology Clinical Trials at Mayo Clinic

Back To Top

Mayo Clinic Gastroenterology & Hepatology 2015

Feb. 23-27, 2015, in Maui, Hawaii
This course covers a wide range of topics in gastroenterology, hepatology and endoscopy.

Mayo Clinic Gastroenterology & Hepatology Southwest Regional Course 2015

Oct. 10, 2015, in Phoenix
Designed for local and regional gastroenterologists, family and internal medicine providers, and advanced practice professionals, this course will combine the best of Digestive Disease Week 2015 and the Mayo Gastroenterology & Hepatology 2015 CME course.

See all Gastroenterology Continuous Professional Development courses

Back To Top
In the Video Center

Bedside to Bench to Bedside: Individualizing Diagnosis and Therapy for Irritable Bowel Syndrome (IBS)
In this Grand Rounds presentation, Arthur Beyder, M.D., Ph.D., and Gianrico Farrugia, M.D., discuss the effects of SCN5A mutations and polymorphisms on Nav1.5 ion channels in IBS and restoration of loss of function with mexiletine.

Visit the Medical Professional Video Center to view specialty and Grand Rounds presentations

Back To Top
Consults & Referrals

Back To Top

Back To Top

Comments Comments?
We're interested in your feedback about this newsletter
Mayo Clinic

13400 East Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905

Share Pass It On!
Invite a friend to subscribe by forwarding this newsletter

Mayo Clinic shield logo | Newsletter Archive | Contact | Medical Professionals

© 2015 Mayo Foundation for Medical Education and Research
200 First Street SW, Rochester, MN 55905. All rights reserved.
Terms of Use